Letters2 August 2011Hepatitis B Virus in the United StatesSu H. Wang, MD, MPH, Perry Pong, MD, and Henry Pollack, MDSu H. Wang, MD, MPHFrom Charles B. Wang Community Health Center, New York, NY 10013, and New York University School of Medicine, New York, NY 10016.Search for more papers by this author, Perry Pong, MDFrom Charles B. Wang Community Health Center, New York, NY 10013, and New York University School of Medicine, New York, NY 10016.Search for more papers by this author, and Henry Pollack, MDFrom Charles B. Wang Community Health Center, New York, NY 10013, and New York University School of Medicine, New York, NY 10016.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-155-3-201108020-00020 SectionsSupplemental MaterialAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail This article has been corrected. The original version (PDF) is appended to this article as a supplement.TO THE EDITOR:We read Ioannou's article (1) with great interest. Accurate estimates of hepatitis B virus (HBV) infection and immunity are important for targeting disease prevention and treatment efforts. Because persons of Asian and Pacific Islander descent account for more than 50% of cases of chronic HBV infection in the United States (2), the underrepresentation of these populations in Ioannou's study should not be downplayed. Asians and Pacific Islanders make up 5% of the U.S. population but are classified as “other race” ...